Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374595 · ClinicalTrials.gov registry record
Vascular Risk After Kidney Transplantation
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 338
- Enrollment target
NCT00374595 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 338 participants.
The verdict
NCT00374595 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional cardiovascular disease risk factors best predict progression of cardiovascular disease (CVD) using carotid intima media thickness performed by ultrasound, in kidney transplant patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2006-04 |
| Est. Completion | 2023-06-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374595
The ClinicalTrials.gov registry entry for NCT00374595 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00374595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374595 about?
NCT00374595 is a clinical study titled "Vascular Risk After Kidney Transplantation". Hypothesis: Nontraditional risk factors, such as inflammation, vitamin D deficiency, elevated PTH, insulin resistance, homocysteine, or uric acid, contribute to cardiovascular disease progression after kidney transplant. The purpose of this study is to evaluate which traditional and nontraditional ...
What is the current status of trial NCT00374595?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2006-04. Estimated completion is 2023-06-20.
Who is sponsoring clinical trial NCT00374595?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.